TLR4 and ulcerative colitis: Our research team found that EMO can exert anti-inflammatory effects through modulation of the Toll-like receptor 4/nuclear factor kappa-B (TLR4/NF-κB) signaling pathway for the treatment of ulcerative colitis [15].